ÂÜÀòÂÒÂ×

Professor Jim Patrick was part of the early development team of the cochlear implant. He went on to help Cochlear Limited grow to a $10B company supplying implants to over 400,000 hearing-impaired people worldwide. Dr. Patrick applies decades of experience taking technology from the lab to global medical markets to his role as Chair of the iBIONICS Advisory Board. He actively participates in growth planning, positioning the company to successfully meet its global commercial aspirations. The advisory focus includes strategic investment partners, manufacturing, distribution, patient outreach, patient experience, regulatory procedures, innovative thinking, and quality assurance protocols.